Itaúsa releases transcript of 2Q26 earnings webcast

Reuters2026/09/11 17:55

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Itaúsa released a transcript of its 1H26 results webcast held Aug. 11, attended by CEO and IR head Alfredo Setubal, CFO Priscila Grecco.
Net profit reached R$ 9.6 billion, up 22%; recurring profit was R$ 8.8 billion, up 12%, excluding R$ 857 million Itautec gains.
Management flagged a slow-growth outlook, high household leverage, election-related uncertainty, possible credit deterioration, risk of mild recession in 2027.
Holding expects PIS/COFINS expense on JCP to end in 2027; cited R$ 860 million cost in 2025, cash freed first for replenishment.
No share buyback under review; only 5,000,000 shares repurchased for long-term incentive plans, dividends policy unchanged through 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Itaúsa SA published the original content used to generate this news brief on September 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经•2026/09/14 00:46

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

Reuters•2026/09/14 00:39

Oman postpones the meeting originally scheduled for the 14th with Iran and other countries; the US warns: Don't expect a breakthrough in the Strait of Hormuz

华尔街见闻•2026/09/14 00:23